Suppr超能文献

考察一项多地点循证干预措施以减少氟喹诺酮类药物使用情况的实施:对员工访谈进行定性内容分析以确定促进因素和障碍。

Examining the implementation of a multi-site evidence-based intervention to reduce fluoroquinolone usage: A qualitative content analysis of staff interviews to identify facilitators and barriers.

作者信息

Solomon Demetrius, Moon Jukrin, Parmasad Vishala, Hernandez Sara, Wiegmann Douglas, Safdar Nasia

机构信息

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Department of Industrial and Systems Engineering, University of Iowa, Iowa City, IA, USA.

出版信息

Appl Ergon. 2025 May;125:104419. doi: 10.1016/j.apergo.2024.104419. Epub 2024 Dec 4.

Abstract

UNLABELLED

Clostridioides difficile infection is the most common healthcare-associated infection, causing almost half a million infections in the United States annually. Inappropriate antibiotic usage is a known risk factor. Antibiotic stewardship efforts aim to optimize prescribing. Evidence supports pre-prescription authorization as a highly effective intervention. A pre-prescription intervention for fluoroquinolone antibiotics via a computerized clinical decision support tool called a "best practice alert" (BPA) embedded in the patient's electronic health records has high potential for improving antibiotic stewardship. However, information is scant about the factors that might impact the uptake and effectiveness of this BPA and other similar evidence-based interventions when spread and adopted across multiple independent sites. Therefore, we utilized the Consolidated Framework for Implementation Research (CFIR) to understand the facilitators and barriers to the implementation process that influence clinical and implementation outcomes. In doing so, we conducted semi-structured interviews with 18 healthcare professionals across four hospitals. Our research team performed a qualitative analysis to understand the contextual factors influencing the implementation outcomes, such as acceptability and sustainability.

TAKEAWAYS

The following themes highlight the factors affecting the implementation of this healthcare innovation.

INTERVENTION CHARACTERISTICS DOMAIN

Designing interventions that are customizable and low maintenance.

INNER SETTING DOMAIN

Maturity level of the Antibiotic Stewardship Program.

INDIVIDUALS DOMAIN

Implementer's experience/attitudes in implementing healthcare innovations.

OUTER SETTING DOMAIN

The ability to prioritize initiatives as the organization responds to unintended circumstances (e.g., COVID).

PROCESS DOMAIN

Adapting implementation approaches and strategies as technology spreads.

摘要

未标注

艰难梭菌感染是最常见的医疗保健相关感染,在美国每年导致近50万例感染。不适当使用抗生素是已知的风险因素。抗生素管理措施旨在优化处方。有证据支持处方前授权是一种高效干预措施。通过嵌入患者电子健康记录中的名为“最佳实践警报”(BPA)的计算机化临床决策支持工具对氟喹诺酮类抗生素进行处方前干预,在改善抗生素管理方面具有很大潜力。然而,关于在多个独立地点推广和采用时可能影响这种BPA及其他类似循证干预措施的采用率和有效性的因素,相关信息却很少。因此,我们利用实施研究综合框架(CFIR)来了解影响临床和实施结果的实施过程中的促进因素和障碍。在此过程中,我们对四家医院的18名医疗保健专业人员进行了半结构化访谈。我们的研究团队进行了定性分析,以了解影响实施结果的背景因素,如可接受性和可持续性。

要点

以下主题突出了影响这一医疗创新实施的因素。

干预特征领域

设计可定制且维护成本低的干预措施。

内部环境领域

抗生素管理计划的成熟程度。

个体领域

实施者在实施医疗创新方面的经验/态度。

外部环境领域

组织应对意外情况(如新冠疫情)时对各项举措进行优先排序的能力。

过程领域

随着技术传播调整实施方法和策略。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验